Tempus AI Debt to Equity Ratio 2023-2025 | TEM

Current and historical debt to equity ratio values for Tempus AI (TEM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Tempus AI debt/equity for the three months ending March 31, 2025 was 2.45.
Tempus AI Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $1.22B $0.33B 3.73
2024-12-31 $0.87B $0.06B 15.44
2024-09-30 $0.92B $0.05B 17.09
2024-06-30 $0.77B $0.10B 7.80
2024-03-31 $1.94B $-1.47B -1.32
2023-12-31 $1.95B $-1.38B -1.41
2023-09-30 $0.00B $0.00B 0.00
2023-06-30 $0.00B $0.00B 0.00
2023-03-31 $0.00B $0.00B 0.00
2022-12-31 $1.76B $-1.13B -1.56
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.867B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.242B 54.20
Hims & Hers Health (HIMS) United States $14.325B 148.84
Inspire Medical Systems (INSP) United States $4.712B 73.62
IRhythm Technologies (IRTC) United States $4.463B 0.00
Privia Health (PRVA) United States $2.963B 202.50
Enovis (ENOV) United States $2.134B 11.90
Schrodinger (SDGR) United States $1.735B 0.00
Clover Health Investments, Corp. (CLOV) US $1.691B 0.00
Phreesia (PHR) United States $1.534B 0.00
Omnicell (OMCL) United States $1.312B 23.14
Azenta, Inc. (AZTA) US $1.233B 57.32
10x Genomics (TXG) United States $1.180B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network, Inc. (BFLY) US $0.571B 0.00
Talkspace (TALK) United States $0.514B 153.50
Veradigm (MDRX) United States $0.455B 0.00
Claritev Corporation (CTEV) US $0.435B 0.00
Standard BioTools (LAB) United States $0.433B 0.00
TruBridge (TBRG) United States $0.375B 831.67
Health Catalyst (HCAT) United States $0.299B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.208B 0.00
Nyxoah SA (NYXH) Belgium $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.156B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
American Well Corporation (AMWL) US $0.111B 0.00
CareCloud, Inc. (CCLD) US $0.086B 3.27
MDxHealth SA (MDXH) Belgium $0.084B 0.00
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
111 (YI) China $0.068B 0.00
Outset Medical (OM) United States $0.062B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
HeartBeam, Inc. (BEAT) US $0.054B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings Inc. (BFRG) US $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00